For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
Twitter
Facebook-f
News
All
Press
Media
Events
Other
CEO Koji Tanabe presents at the 5th World Science and Technology Development Forum in China
•
November 30, 2023
•
Events
I Peace, Inc. is shortlisted for the 2024 Advanced Therapies Awards
•
November 10, 2023
•
Other
Using GMP iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine
•
November 2, 2023
•
Press
Personal iPS cell banking service “My Peace” website launched
•
October 12, 2023
•
Other
Kyoto University Students Visit I Peace’s Head Office
•
September 19, 2023
•
Other
I Peace was featured on TV Tokyo’s Program
•
July 3, 2023
•
Other
I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with “Special Recognition in Cell Therapy”
•
December 22, 2022
•
Press
I Peace partners with the California Institute for Regenerative Medicine [CIRM]
•
November 1, 2022
•
Other
CEO Koji Tanabe presents at the 2022 International Summit Forum on Cell Therapy and Regenerative Medicine in Taiwan
•
October 28, 2022
•
Events
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming
•
September 20, 2022
•
Press
Reach out to us to learn more
Contact Us